Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-7-14
|
pubmed:abstractText |
1. We examined the effects of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), a beta-carboline inverse agonist for the benzodiazepine site, on gamma-aminobutyric acid (GABA)-induced Cl-currents in several cloned rat GABAA receptor subtypes expressed in human embryonic kidney cells. The Cl- currents were measured in the whole cell configuration of patch clamp techniques. 2. DMCM at low concentrations (< 0.5 microM) occupying only the benzodiazepine site decreased GABA-induced Cl currents in the alpha 1 beta 2 gamma 2 and alpha 3 beta 2 gamma 2 subtypes as expected from an inverse agonist, but produced no change in the alpha 6 beta 2 gamma 2 subtype (perhaps a neutral antagonist). The drug at higher concentrations (> 0.5 microM) enhanced Cl- currents in all the subtypes with a half maximal concentration of 6 to 20 microM, depending on the alpha isoform. In the alpha 1 beta 2 subtype, which is without the benzodiazepine site, DMCM monophasically increased Cl- currents with a half maximal concentration of 1.9 microM. 3. Ro 15-1788 (a classical benzodiazepine antagonist) had no effect on Cl- current enhancement by DMCM and, in fact, increased the current level through blocking current inhibition by DMCM via the benzodiazepine site. Also, Cl- current enhancement by pentobarbitone or by 3 alpha, 21-dihydroxy-5 alpha-pregnan-20-one was additive to that by DMCM at saturating doses. It appears that the agonist site for DMCM is distinct from those for benzodiazepines, barbiturates and neurosteroids. 4. Among beta-carboline analogues, methyl-beta-carboline-3-carboxylate and propyl-beta-carboline-3-carboxylate markedly enhanced GABA-induced Cl currents in the alpha 1 beta 2 gamma 2 subtype, while N-methyl-beta-carboline-3-carboxamide and 1-methyl-7-methoxy-3,4-dihydro-beta-carboline did not. It appears that the 3-carboxyl ester moiety is necessary for beta-carbolines to interact with a novel site on GABAA receptors as agonists.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-1338138,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-2166916,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-2538761,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-6270629,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-6281892,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-7687050,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7780638-8018215
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Barbiturates,
http://linkedlifedata.com/resource/pubmed/chemical/Carbolines,
http://linkedlifedata.com/resource/pubmed/chemical/Chloride Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Convulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Flumazenil,
http://linkedlifedata.com/resource/pubmed/chemical/GABA Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, GABA-A,
http://linkedlifedata.com/resource/pubmed/chemical/Steroids,
http://linkedlifedata.com/resource/pubmed/chemical/methyl...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0007-1188
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1040-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7780638-Barbiturates,
pubmed-meshheading:7780638-Carbolines,
pubmed-meshheading:7780638-Cell Line,
pubmed-meshheading:7780638-Chloride Channels,
pubmed-meshheading:7780638-Convulsants,
pubmed-meshheading:7780638-Flumazenil,
pubmed-meshheading:7780638-GABA Antagonists,
pubmed-meshheading:7780638-GABA-A Receptor Agonists,
pubmed-meshheading:7780638-Humans,
pubmed-meshheading:7780638-Kidney,
pubmed-meshheading:7780638-Patch-Clamp Techniques,
pubmed-meshheading:7780638-Plasmids,
pubmed-meshheading:7780638-Receptors, GABA-A,
pubmed-meshheading:7780638-Steroids
|
pubmed:year |
1995
|
pubmed:articleTitle |
Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
|
pubmed:affiliation |
CNS Diseases Research, Upjohn Company, Kalamazoo, MI 49001, USA.
|
pubmed:publicationType |
Journal Article
|